2226-86-0

Basic information

• Product Name: ETHYL-2,4-DIMETHYL-5-PYRIMIDINE CARBOXYLATE
• Synonyms: ETHYL-2,4-DIMETHYL-5-PYRIMIDINE CARBOXYLATE;2,4-DiMethyl-pyriMidine-5-carboxylic acid ethyl ester;NSC 165510
• CAS NO: 2226-86-0
• Molecular Formula: C₉H₁₂N₂O₂
• Molecular Weight: 180.2
• Mol File: 2226-86-0.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 252℃
• Flash Point: 107℃
• Appearance: /
• Density: 1.106
• Vapor Pressure: 0.0192mmHg at 25°C
• Refractive Index: 1.4942
• Storage Temp.: 2-8°C
• CAS DataBase Reference: ETHYL-2,4-DIMETHYL-5-PYRIMIDINE CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL-2,4-DIMETHYL-5-PYRIMIDINE CARBOXYLATE(2226-86-0)
• EPA Substance Registry System: ETHYL-2,4-DIMETHYL-5-PYRIMIDINE CARBOXYLATE(2226-86-0)

Safety Data

• Hazardous Substances Data: 2226-86-0(Hazardous Substances Data)

Usage

General Description

ETHYL-2,4-DIMETHYL-5-PYRIMIDINE CARBOXYLATE is a chemical compound with the molecular formula C9H12N2O2. It is a pyrimidine derivative with two methyl groups and an ethyl ester group. ETHYL-2,4-DIMETHYL-5-PYRIMIDINE CARBOXYLATE is used in various chemical processes, including as a building block in organic synthesis and pharmaceutical research. It may also have potential applications in the development of new drugs or agrochemicals.ETHYL-2,4-DIMETHYL-5-PYRIMIDINE CARBOXYLATE is a white crystalline solid with a melting point of around 80-84°C and is soluble in organic solvents such as ethanol and acetone. It is important to handle and use this chemical with caution, following proper safety measures and guidelines, as it may pose health hazards if not handled properly.

InChI:InChI=1/C9H12N2O2/c1-4-13-9(12)8-5-10-7(3)11-6(8)2/h5H,4H2,1-3H3

Upstream product

• 49836-24-0 (E)-2-(ethoxymethylene)-3-oxobutanoic acid ethyl ester 
• 143-37-3 acetamidine 
• 141-97-9 ethyl acetoacetate 
• 124-42-5 acetamidine hydrochloride 
• 134653-70-6 α-acetyl-α-(dimethylaminomethylene)acetic acid,ethyl ester 
• 134653-70-6 ethyl 2-[(dimethylamino)methylene]-3-oxobutanoate 
• 66975-53-9 2-1-ethoxy-meth-(Z)-ylidene-3-oxo-butyric acid ethyl ester 
• 3788-94-1 2-ethoxymethylene-3-oxobutanoic acid ethyl ester 

Downstream Products

• 74840-41-8 α-(2,4-dimethyl-5-pyrimidinyl)benzhydrol 
• 74356-36-8 2,4-dimethylpyrimidine-5-carboxylic acid 
• 88317-45-7 2,4-dimethylpyrimidine-5-carbohydrazide 
• 108718-87-2 N-acetyl-sulfanilic acid-(2,4-dimethyl-pyrimidin-5-ylamide) 
• 7411-79-2 2,4-dimethyl-4-amino-N-5-pyrimidinylbenzenesulfonamide 
• 35733-53-0 5-amino-2,4-dimethylpyrimidine 
• 74840-42-9 (2,4-dimethyl-5-pyrimidinyl)diphenyl-(1-imidazolyl)methane 
• 53554-30-6 2,4-Dimethyl-pyrimidin-5-carbonsaeure-amid 
• 14331-54-5 2,4-dimethylpyrimidine 

Relevant articles and documents

Pyrido/pyridazocyclic compound and application thereof

The invention discloses a pyrido/pyridazocyclic compound, a pharmaceutically acceptable salt and a solvent compound thereof. The invention further provides a preparation method of the compound, a composition with the compound and application of the compound for preparing medicines for treating diseases or disorders related to EED (embryonic ectoderm development) protein and/or PRC2 (polycomb repressive complex 2) protein composition action mechanisms.

Dpp-IV inhibitors

The invention relates to compounds of formula (I) wherein R1, R2, R3 and n have the meaning as cited in the description and the claims. Said compounds are useful as DPP-IV inhibitors. The invention also relates to the prep

MEDICINAL COMPOSITIONS

The present invention relates to an agent for the prophylaxis or treatment of pain, an agent for suppressing activation of osteoclast, and an inhibitor of osteoclast formation, which contains a p38 MAP kinase inhibitor and/or a TNF-α production inhibitor.